Verve Therapeutics, Inc. - COM (VERV)

Historical Portfolio Holders from Q2 2021 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
75.2M
Holdings value Q3 2024
$364M
Value change Q3 2024
-$7.26M
Grand Portfolio weight change Q3 2024
0%
Number of holders
167
Number of buys Q3 2024
89
Number of sells Q3 2024
-68
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 75.2M $364M -$7.26M $4.84 168
2024 Q2 76.1M $371M -$40.9M $4.88 161
2024 Q1 81.6M $1.08B +$94.9M $13.28 160
2023 Q4 74.7M $1.04B +$151M $13.94 153
2023 Q3 63.9M $847M +$20.6M $13.26 130
2023 Q2 61.9M $1.16B -$19.8M $18.75 116
2023 Q1 63.3M $912M +$3.33M $14.42 122
2022 Q4 62.6M $1.21B +$9.15M $19.35 117
2022 Q3 60.7M $2.08B +$501M $34.35 121
2022 Q2 45.6M $696M -$28.5M $15.28 94
2022 Q1 46.6M $1.06B +$20M $22.82 91
2021 Q4 45.1M $1.66B +$125M $36.87 89
2021 Q3 38.7M $1.81B +$21.7M $47.00 72
2021 Q2 37.7M $2.25B +$2.25B $60.25 69